IRMD - IRadimed Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$120.00
DETAILS
HIGH:
$120.00
LOW:
$120.00
MEDIAN:
$120.00
CONSENSUS:
$120.00
UPSIDE:
30.29%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 83.8 | 73.2 | 65.6 | 53.3 | 41.8 | 31.7 | 38.5 | 30.4 | 23.1 | 32.5 | 31.6 | 15.7 | 11.3 | 7.7 |
| Cost of Revenue | 19.5 | 16.9 | 15.4 | 12.0 | 9.8 | 8.1 | 8.8 | 7.2 | 5.6 | 6.2 | 5.8 | 3.4 | 2.9 | 2.1 |
| Gross Profit | 64.3 | 56.3 | 50.2 | 41.3 | 32.0 | 23.6 | 29.7 | 23.2 | 17.5 | 26.3 | 25.8 | 12.2 | 8.5 | 5.6 |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 3.0 | 2.8 | 2.9 | 2.3 | 1.9 | 1.9 | 1.4 | 1.5 | 1.7 | 1.3 | 1.8 | 1.1 | 1.0 | 0.7 |
| SG&A Expenses | 35.2 | 31.6 | 27.3 | 23.4 | 20.3 | 22.4 | 19.6 | 15.7 | 14.5 | 14.1 | 12.5 | 8.1 | 4.7 | 3.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.0 | 0.1 | (0.0) | (0.0) | 0.0 |
| Operating Expenses | 38.2 | 34.4 | 30.1 | 25.7 | 22.2 | 24.3 | 21.1 | 17.2 | 16.2 | 15.4 | 14.2 | 9.2 | 5.7 | 4.1 |
| Operating Income | ||||||||||||||
| Operating Income | 26.1 | 22.0 | 20.0 | 15.6 | 9.8 | (0.8) | 8.6 | 6.0 | 1.3 | 10.9 | 11.5 | 3.1 | 2.8 | 1.4 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 2.2 | 1.9 | 0.6 | 0.0 | 0.1 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0 | 0 |
| Profitability | ||||||||||||||
| EBITDA | 28.5 | 22.8 | 20.8 | 16.3 | 11.2 | 0.6 | 9.9 | 7.1 | 2.6 | 11.2 | 11.5 | 3.2 | 2.9 | 1.5 |
| EBIT | 26.1 | 22.0 | 20.0 | 15.6 | 9.8 | (0.8) | 8.6 | 6.2 | 1.4 | 11.0 | 11.6 | 3.0 | 2.8 | 1.4 |
| Income Before Tax | 28.4 | 24.3 | 21.7 | 16.2 | 9.8 | (0.6) | 9.0 | 6.2 | 1.4 | 11.0 | 11.6 | 3.0 | 2.8 | 1.4 |
| Income Tax Expense | 5.9 | 5.0 | 4.5 | 3.4 | 0.5 | (2.0) | (0.6) | (0.1) | 0.9 | 3.7 | 4.1 | 1.0 | 0.8 | 0.5 |
| Net Income | 22.5 | 19.2 | 17.2 | 12.8 | 9.3 | 1.4 | 9.6 | 6.3 | 0.5 | 7.2 | 7.5 | 2.1 | 1.9 | 1.0 |
| Per Share Data | ||||||||||||||
| EPS (Basic) | 1.77 | 1.52 | 1.36 | 1.02 | 0.76 | 0.11 | 0.85 | 0.52 | 0.05 | 0.67 | 0.68 | 0.23 | 0.19 | 0.09 |
| EPS (Diluted) | 1.75 | 1.50 | 1.35 | 1.02 | 0.74 | 0.11 | 0.78 | 0.52 | 0.04 | 0.60 | 0.60 | 0.20 | 0.19 | 0.09 |
| Shares Outstanding | 12.7 | 12.7 | 12.6 | 12.6 | 12.3 | 12.1 | 11.3 | 12.1 | 10.6 | 10.8 | 11.0 | 8.7 | 10.4 | 10.4 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 51.2 | 52.2 | 49.8 | 58.0 | 62.0 | 50.1 | 43.5 | 28.0 | 18.2 | 17.7 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0.5 | 1.9 | 2.8 | 6.3 | 8.1 | 8.0 |
| Net Receivables | 13.7 | 10.6 | 12.2 | 13.3 | 5.1 | 4.6 | 7.3 | 4.2 | 3.8 | 3.8 |
| Inventory | 11.6 | 10.4 | 12.8 | 5.4 | 4.3 | 3.9 | 3.6 | 4.1 | 4.2 | 3.9 |
| Other Current Assets | 4.8 | 2.0 | 1.2 | 0.6 | 1.0 | 0.8 | 0.4 | 0.5 | 0.6 | 0.7 |
| Total Current Assets | 81.2 | 75.2 | 76.0 | 77.5 | 76.2 | 63.7 | 59.0 | 44.5 | 35.1 | 34.2 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 23.9 | 17.0 | 11.3 | 4.6 | 4.6 | 4.8 | 5.0 | 1.9 | 1.9 | 1.5 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.4 | 3.1 | 2.5 | 2.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.9 | 0.9 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.2 | 0.2 | 0.2 | 0.6 | 0.2 | 0.3 | 0.2 | 0.1 | 0.2 | 0.2 |
| Total Non-Current Assets | 27.6 | 23.1 | 16.2 | 8.0 | 6.6 | 7.3 | 7.8 | 3.9 | 3.9 | 3.0 |
| Total Assets | 108.8 | 98.3 | 92.2 | 85.5 | 82.9 | 71.1 | 66.7 | 48.4 | 39.0 | 37.2 |
| Current Liabilities | ||||||||||
| Account Payables | 1.8 | 1.9 | 1.9 | 1.8 | 0.8 | 0.7 | 1.0 | 0.8 | 0.7 | 1.1 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 2.9 | 2.3 | 2.6 | 3.4 | 2.6 | 1.9 | 1.7 | 1.8 | 1.6 | 1.0 |
| Other Current Liabilities | 0.5 | 0.3 | 0.4 | 0.1 | 0.3 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 |
| Total Current Liabilities | 10.2 | 8.5 | 16.3 | 8.6 | 6.8 | 4.9 | 5.9 | 4.7 | 4.1 | 3.7 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 4.0 | 3.0 | 4.4 | 3.3 | 3.9 | 4.8 | 5.3 | 1.8 | 2.0 | 1.6 |
| Total Liabilities | 14.2 | 11.5 | 20.7 | 11.8 | 10.7 | 9.7 | 11.2 | 6.5 | 6.1 | 5.3 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | 64.2 | 56.8 | 43.3 | 47.3 | 47.0 | 37.7 | 36.3 | 26.7 | 20.4 | 19.9 |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | (0.0) | (0.0) | (0.0) |
| Total Stockholders' Equity | 94.6 | 86.8 | 71.4 | 73.7 | 72.2 | 61.4 | 55.5 | 41.9 | 32.9 | 31.9 |
| Total Liabilities & Equity | 108.8 | 98.3 | 92.2 | 85.5 | 82.9 | 71.1 | 66.7 | 48.4 | 39.0 | 37.2 |
| Debt Metrics | ||||||||||
| Total Debt | 0 | 0.2 | 2.0 | 2.2 | 2.5 | 2.7 | 3.0 | 0 | 0 | 0 |
| Net Debt | (51.2) | (52.1) | (47.7) | (55.8) | (59.5) | (47.4) | (40.5) | (28.0) | (18.2) | (17.7) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 22.5 | 19.2 | 17.2 | 12.8 | 9.3 | 1.4 | 9.6 | 6.3 | 0.5 | 7.2 |
| Depreciation & Amortization | 1.2 | 0.8 | 0.8 | 0.7 | 1.4 | 1.3 | 1.2 | 1.1 | 1.3 | 0.2 |
| Stock-Based Compensation | 2.9 | 2.5 | 2.2 | 1.4 | 1.5 | 4.0 | 1.9 | 1.8 | 2.5 | 1.8 |
| Change in Working Capital | (4.3) | 3.7 | (5.9) | (5.1) | (1.6) | (1.2) | (2.0) | (1.8) | (1.1) | 0.5 |
| Other Non-Cash Items | 2.7 | (0.0) | 0.4 | 0.1 | 0.1 | (0.1) | 0.1 | 0.2 | 0.4 | 570,909.6 |
| Operating Cash Flow | 24.9 | 25.6 | 13.5 | 10.0 | 11.3 | 5.8 | 10.2 | 7.4 | 3.4 | 9.4 |
| Investing Activities | ||||||||||
| Capital Expenditure | (7.8) | (8.0) | (8.0) | (1.9) | (0.7) | (0.6) | (0.5) | (0.3) | (0.8) | (1.5) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.7 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1.1) | (2.7) | (5.0) |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0.5 | 1.4 | 0.9 | 3.7 | 2.9 | 2.5 | 4.6 |
| Other Investing Activities | (0.7) | (0.8) | (0.6) | (1.1) | (0.3) | 0 | (0.1) | (0.0) | (0.0) | (0.7) |
| Investing Cash Flow | (8.4) | (8.8) | (8.0) | (1.4) | 0.6 | 0.2 | 3.2 | 1.5 | (1.0) | (1.9) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.3) | (1.8) | (10.0) |
| Dividends Paid | (15.0) | (13.7) | (13.2) | (12.6) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.6) | (0.7) | (0.4) | (0.1) | 0.0 | (1.2) | 2.0 | 0.9 | (0.1) | 0.9 |
| Financing Cash Flow | (17.6) | (14.3) | (13.7) | (12.7) | 0.0 | 0.5 | 2.0 | 0.9 | (1.9) | (9.1) |
| Cash Position | ||||||||||
| Net Change in Cash | (1.1) | 2.5 | (8.2) | (4.0) | 11.9 | 6.6 | 15.5 | 9.8 | 0.5 | (1.7) |
| Cash at Beginning | 52.2 | 49.8 | 58.0 | 62.0 | 50.1 | 43.5 | 28.0 | 18.2 | 17.7 | 19.4 |
| Cash at End | 51.2 | 52.2 | 49.8 | 58.0 | 62.0 | 50.1 | 43.5 | 28.0 | 18.2 | 17.7 |
| Free Cash Flow | 17.2 | 17.6 | 5.5 | 8.2 | 10.5 | 5.2 | 9.7 | 7.1 | 2.6 | 7.9 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 83.8 | 73.2 | 65.6 | 53.3 | 41.8 | 31.7 | 38.5 | 30.4 | 23.1 | 32.5 | 31.6 | 15.7 | 11.3 | 7.7 |
| Gross Profit | 64.3 | 56.3 | 50.2 | 41.3 | 32.0 | 23.6 | 29.7 | 23.2 | 17.5 | 26.3 | 25.8 | 12.2 | 8.5 | 5.6 |
| Operating Income | 26.1 | 22.0 | 20.0 | 15.6 | 9.8 | (0.8) | 8.6 | 6.0 | 1.3 | 10.9 | 11.5 | 3.1 | 2.8 | 1.4 |
| Net Income | 22.5 | 19.2 | 17.2 | 12.8 | 9.3 | 1.4 | 9.6 | 6.3 | 0.5 | 7.2 | 7.5 | 2.1 | 1.9 | 1.0 |
| EPS (Diluted) | 1.75 | 1.50 | 1.35 | 1.02 | 0.74 | 0.11 | 0.78 | 0.52 | 0.04 | 0.60 | 0.60 | 0.20 | 0.19 | 0.09 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 51.2 | 52.2 | 49.8 | 58.0 | 62.0 | 50.1 | 43.5 | 28.0 | 18.2 | 17.7 | ||||
| Total Assets | 108.8 | 98.3 | 92.2 | 85.5 | 82.9 | 71.1 | 66.7 | 48.4 | 39.0 | 37.2 | ||||
| Total Debt | 0 | 0.2 | 2.0 | 2.2 | 2.5 | 2.7 | 3.0 | 0 | 0 | 0 | ||||
| Stockholders' Equity | 94.6 | 86.8 | 71.4 | 73.7 | 72.2 | 61.4 | 55.5 | 41.9 | 32.9 | 31.9 | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | 24.9 | 25.6 | 13.5 | 10.0 | 11.3 | 5.8 | 10.2 | 7.4 | 3.4 | 9.4 | ||||
| Capital Expenditure | (7.8) | (8.0) | (8.0) | (1.9) | (0.7) | (0.6) | (0.5) | (0.3) | (0.8) | (1.5) | ||||
| Free Cash Flow | 17.2 | 17.6 | 5.5 | 8.2 | 10.5 | 5.2 | 9.7 | 7.1 | 2.6 | 7.9 | ||||